Orthopaedics and cardiology groups start to improve in terms of sales per employee, but Covid test makers do better still.
The worst half-year period for a decade leaves the biggest medical device companies half a trillion dollars poorer.
The robotic surgery giant is finally being challenged by companies even bigger than itself.
Staffing levels changed little across 2020 as M&A slowed – but sales are another story.
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.